Moderna seeks FDA authorization for updated COVID vaccine to tackle dominant strain

TL;DR Summary
The FDA is recommending updated COVID-19 vaccines for the fall, with a monovalent XBB 1.5 composition to match the circulating variants. Local health departments in Ohio are continuing to offer bivalent boosters and encouraging vaccinations, while reporting a drop in interest in vaccines. Ohio has seen a dramatic decrease in COVID cases, hospitalizations, and deaths compared to the same time frame last year, attributed to immunity gained from vaccinations and/or infections. Vaccinations are still stressed as the most important tool in avoiding catching COVID.
- Ohio COVID cases dramatically down: See what vaccine FDA is recommending in fall Dayton Daily News
- CDC Data: 'Arcturus' Causing 20% of New COVID-19 Infections U.S. News & World Report
- Moderna Files for FDA Authorization of Updated COVID-19 Vaccine Drug Topics
- Moderna seeks US FDA authorization for updated COVID vaccine Yahoo! Voices
- Moderna Seeks FDA Nod For Updated COVID-19 Vaccine To Tackle Dominant Strain: The Hill - Moderna (NASDAQ: Benzinga
- View Full Coverage on Google News
Reading Insights
Total Reads
0
Unique Readers
8
Time Saved
5 min
vs 5 min read
Condensed
91%
985 → 84 words
Want the full story? Read the original article
Read on Dayton Daily News